Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 217

1.

Vaccination against influenza: role and limitations in pandemic intervention plans.

Rebmann T, Zelicoff A.

Expert Rev Vaccines. 2012 Aug;11(8):1009-19. Review.

PMID:
23002981
2.

Obstetricians and the 2009-2010 H1N1 vaccination effort: implications for future pandemics.

Clark SJ, Cowan AE, Wortley PM.

Matern Child Health J. 2013 Sep;17(7):1185-90. doi: 10.1007/s10995-012-1104-x.

3.

A note on the use of influenza vaccination strategies when supply is limited.

Lee S, Morales R, Castillo-Chavez C.

Math Biosci Eng. 2011 Jan;8(1):171-82. doi: 10.3934/mbe.2011.8.171.

PMID:
21361406
4.

Uptake of pandemic influenza (H1N1)-2009 vaccines in Brazil, 2010.

Domingues CM, de Oliveira WK; Brazilian Pandemic Influenza Vaccination Evaluation Team.

Vaccine. 2012 Jul 6;30(32):4744-51. doi: 10.1016/j.vaccine.2012.05.007. Epub 2012 May 18. Review.

PMID:
22609010
5.

Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China.

Seale H, Kaur R, Wang Q, Yang P, Zhang Y, Wang X, Li X, Zhang H, Zhang Z, MacIntyre CR.

Vaccine. 2011 Feb 11;29(8):1605-10. doi: 10.1016/j.vaccine.2010.12.077. Epub 2011 Jan 4.

PMID:
21211593
6.

Pandemic influenza A (H1N1) 2009 vaccine: an update.

Goel MK, Goel M, Khanna P, Mittal K.

Indian J Med Microbiol. 2011 Jan-Mar;29(1):13-8. doi: 10.4103/0255-0857.76517. Review.

7.

The development of vaccine viruses against pandemic A(H1N1) influenza.

Robertson JS, Nicolson C, Harvey R, Johnson R, Major D, Guilfoyle K, Roseby S, Newman R, Collin R, Wallis C, Engelhardt OG, Wood JM, Le J, Manojkumar R, Pokorny BA, Silverman J, Devis R, Bucher D, Verity E, Agius C, Camuglia S, Ong C, Rockman S, Curtis A, Schoofs P, Zoueva O, Xie H, Li X, Lin Z, Ye Z, Chen LM, O'Neill E, Balish A, Lipatov AS, Guo Z, Isakova I, Davis CT, Rivailler P, Gustin KM, Belser JA, Maines TR, Tumpey TM, Xu X, Katz JM, Klimov A, Cox NJ, Donis RO.

Vaccine. 2011 Feb 17;29(9):1836-43. doi: 10.1016/j.vaccine.2010.12.044. Epub 2011 Jan 1.

PMID:
21199698
8.

Exploring determinants of acceptance of the pandemic influenza A (H1N1) 2009 vaccination in nurses.

To KW, Lee S, Chan TO, Lee SS.

Am J Infect Control. 2010 Oct;38(8):623-30. doi: 10.1016/j.ajic.2010.05.015. Epub 2010 Jun 20.

PMID:
20566229
9.

Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.

Abelin A, Colegate T, Gardner S, Hehme N, Palache A.

Vaccine. 2011 Feb 1;29(6):1135-8. doi: 10.1016/j.vaccine.2010.11.042. Epub 2010 Nov 27. Review.

10.

Factors influencing pandemic influenza vaccination of healthcare workers--a systematic review.

Prematunge C, Corace K, McCarthy A, Nair RC, Pugsley R, Garber G.

Vaccine. 2012 Jul 6;30(32):4733-43. doi: 10.1016/j.vaccine.2012.05.018. Epub 2012 May 27. Review.

PMID:
22643216
11.

Pandemic influenza A (H1N1) 2009 in a critical care and theatre setting: beliefs and attitudes towards staff vaccination.

Parry HM, Damery S, Fergusson A, Draper H, Bion J, Low AE.

J Hosp Infect. 2011 Aug;78(4):302-7. doi: 10.1016/j.jhin.2011.02.009. Epub 2011 Apr 9.

PMID:
21481491
12.

Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010).

Hanquet G, Van Damme P, Brasseur D, De Cuyper X, Gregor S, Holmberg M, Martin R, Molnár Z, Pompa MG, Snacken R, van der Sande M, Van Ranst M, Wirtz A, Neels P.

Vaccine. 2011 Jan 10;29(3):370-7. doi: 10.1016/j.vaccine.2010.10.079. Epub 2010 Nov 12.

PMID:
21075164
13.

PATH Influenza Vaccine Project: accelerating the development of new influenza vaccines for low-resource countries.

Neuzil KM, Tsvetnitsky V, Nyari LJ, Bright RA, Boslego JW; PATH's Influenza Vaccine Project team.

Expert Rev Vaccines. 2012 Aug;11(8):939-47.

PMID:
23002975
14.

[Tetravaccine--new fundamental approach to prevention of influenza pandemic].

Onishchenko GG, Zverev VV, Katlinskiĭ AV, Semchenko AV, Korovkin SA, Mel'nikov SIa, Mironov AN.

Zh Mikrobiol Epidemiol Immunobiol. 2007 Jul-Aug;(4):15-9. Review. Russian.

PMID:
17882832
15.

[Pandemic vaccines].

Floret D.

Arch Pediatr. 2010 Jun;17(6):906-7. doi: 10.1016/S0929-693X(10)70172-X. French. No abstract available.

PMID:
20654954
16.

CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection.

Schmidt T, Dirks J, Enders M, Gärtner BC, Uhlmann-Schiffler H, Sester U, Sester M.

Eur J Immunol. 2012 Jul;42(7):1755-66. doi: 10.1002/eji.201242393.

17.

Vaccines against influenza A (H1N1) pandemic.

Valdespino-Gomez JL, Garcia-Garcia L, de León-Rosales SP.

Arch Med Res. 2009 Nov;40(8):693-704. doi: 10.1016/j.arcmed.2009.10.008.

PMID:
20304259
18.

Factors associated with uptake of vaccination against pandemic influenza: a systematic review.

Bish A, Yardley L, Nicoll A, Michie S.

Vaccine. 2011 Sep 2;29(38):6472-84. doi: 10.1016/j.vaccine.2011.06.107. Epub 2011 Jul 12. Review.

PMID:
21756960
19.

Development of influenza vaccine production capacity by the Government Pharmaceutical Organization of Thailand: addressing the threat of an influenza pandemic.

Surichan S, Wirachwong P, Supachaturas W, Utid K, Theerasurakarn S, Langsanam P, Lakornrach P, Nitisaporn L, Chansikkakorn C, Vangkanonta W, Kaweepornpoj R, Poopipatpol K, Thirapakpoomanunt S, Srichainak S, Artavatkun W, Chokevivat V, Wibulpolprasert S.

Vaccine. 2011 Jul 1;29 Suppl 1:A29-33. doi: 10.1016/j.vaccine.2011.04.120. Review.

20.

Awareness of the background rate of sudden cardiac death during mass immunization with pandemic H1N1 influenza vaccines increases the intended vaccination rate.

Wang Y, Xiao Z, Wang W.

Prev Med. 2010 Nov;51(5):445-6. doi: 10.1016/j.ypmed.2010.08.019. Epub 2010 Sep 9. No abstract available.

PMID:
20832419

Supplemental Content

Support Center